Molecular Glue Degraders of TEM β‐Lactamases by Periplasmic Protease DegP

ABSTRACT Antimicrobial resistance is one of the most serious challenges to global health, yet the development of new molecules with novel mechanisms of action to combat resistance is lacking. In this study, we report the discovery of molecular glues that recruit TEM‐family β‐lactamases to the bacterial protease DegP for degradation. β‐Lactamase inhibitor tazobactam was found to accelerate degradation of TEM β‐lactamases by DegP, which was further enhanced by linkerless incorporation of dipeptide motifs enriched among DegP substrates. The resulting molecular glue degraders showed improved synergy with β‐lactam piperacillin against resistant Escherichia coli compared to tazobactam, as well as good pharmacokinetic properties for oral dosing. Collectively, this work establishes periplasmic targeted protein degradation as a promising new mechanism for combating β‐lactamase resistance.

Authors

Institutions

Publication Details

Journal
Angewandte Chemie
Published
2026-10-30
DOI
https://doi.org/10.1002/ange.3138186
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular Glue Degraders of TEM β‐Lactamases by Periplasmic Protease DegP

Timothy Rutland Walsh, Frederik Eisele, Thomas Lanyon‐Hogg, Georgia L. Isom et al.
Angewandte Chemie
Antibiotic Resistance in Bacteria
article

Molecular Glue Degraders of TEM β‐Lactamases by Periplasmic Protease DegP

Timothy Rutland Walsh, Frederik Eisele, Thomas Lanyon‐Hogg, Georgia L. Isom, Patrícia Santos Barbosa, Yiqiao Wang, Emilia K. Taylor, Elisabete C.C.M. Moura, Tarini Kadambi
article en

Abstract

ABSTRACT Antimicrobial resistance is one of the most serious challenges to global health, yet the development of new molecules with novel mechanisms of action to combat resistance is lacking. In this study, we report the discovery of molecular glues that recruit TEM‐family β‐lactamases to the bacterial protease DegP for degradation. β‐Lactamase inhibitor tazobactam was found to accelerate degradation of TEM β‐lactamases by DegP, which was further enhanced by linkerless incorporation of dipeptide motifs enriched among DegP substrates. The resulting molecular glue degraders showed improved synergy with β‐lactam piperacillin against resistant Escherichia coli compared to tazobactam, as well as good pharmacokinetic properties for oral dosing. Collectively, this work establishes periplasmic targeted protein degradation as a promising new mechanism for combating β‐lactamase resistance.

Angewandte Chemie
University of Oxford (GB), AstraZeneca (Sweden) (SE)
Wellcome Trust, Royal Society, Medical Research Council, European Research Council
Good health and well-being
Openalex Percentile: Top 22%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Molecular Glue Degraders of TEM β‐Lactamases by Periplasmic Protease DegP — Timothy Rutland Walsh, Frederik Eisele, et al. · Angewandte Chemie (2026) | TGRS Research Map | TGRS